Sanofi Pasteur

Tetraxim is a 4-in-1 booster vaccine distributed in more than 100 countries, informs the company

It is a tele-counselling facility with a toll-free number that registers a parent's missed call and allows a VaxLine health expert…

Work with Biomedical Advanced Research and Development Authority (BARDA) will utilize Sanofi’s well-established recombinant…

It also recognised strong public health benefit to be gained by introduction of Dengvaxia, dengue vaccine

Sanofi Pasteur’s Dengvaxia can be rapidly leveraged to help understand the spread of ZIKV Sanofi Pasteur, the vaccines division…

With 1.4 million dengue cases reported this year, Brazil stands to gain tremendous value from this new dengue prevention tool…

Reaffirms company’s vision for priority introduction of the dengue vaccine in endemic countries globally

First marketing authorization of Dengvaxia is a historic milestone paving the way to significantly impact dengue burden in endemic…

Based on the clinical profile in nine years of age and older, the dengue vaccine candidate has the potential to significantly…

Oncology, autoimmune and infectious diseases/vaccines are areas for novel therapeutics and in vitro diagnostics in 2015